FindTrial
Sign In

Drug resistance patterns in the Pimpri-Chinchwad area of Pune District in Western India and the development of novel diagnostic assays for predicting drug resistance in MTb clinical isolates

Study of the phenotypic and genotypic drug resistance patterns in the Pimpri-Chinchwad area of Pune District in Western India and the development of novel diagnostic assays for predicting drug resistance in Mycobacterium tuberculosis clinical isolates. - TBDR-Pimpri

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/061981
Enrollment
120
Registered
2024-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

None listed

Sponsors

MRIGlobal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with anti-TB drug resistant tuberculosis from the Pimpri Chinchwad area of Pune District

Exclusion criteria

Exclusion criteria: TB patients with age <18 years

Design outcomes

Primary

MeasureTime frame
phenotypic and genotypic drug resistance pattern at one time point at the time on enrollment tuberculosis patients in the Pimpri-Chinchwad area of Pune District in Western India in adults 18 years or moreTimepoint: Observational study with one time point sputum sample collection—

Secondary

MeasureTime frame
To identify molecular markers (DNA and/or RNA) that can be incorporated into a diagnostic test to predict phenotypic resistanceTimepoint: One time point in second year of study—

Countries

India

Contacts

Public ContactSrikanth Tripathy

Dr D Y Patil Medical College, Hosp & Res Centre

srikanthtripathy@gmail.com09500779797

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026